Organization & Developments: Neuromod

Parents

*Neuromod is a medical technology company that uses biomodal neuromodulation to treat tinnitus using its device, Lenire, which received FDA De Novo clearance in 2023
Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
The funds will be used to expand the U.S. and European reach of its FDA-cleared tinnitus treatment device, Lenire, including with the Department of Veterans Affairs.